These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23701235)

  • 1. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking.
    Blaising J; Lévy PL; Gondeau C; Phelip C; Varbanov M; Teissier E; Ruggiero F; Polyak SJ; Oberlies NH; Ivanovic T; Boulant S; Pécheur EI
    Cell Microbiol; 2013 Nov; 15(11):1866-82. PubMed ID: 23701235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking.
    Blaising J; Lévy PL; Polyak SJ; Stanifer M; Boulant S; Pécheur EI
    Antiviral Res; 2013 Oct; 100(1):215-9. PubMed ID: 23981392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
    Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
    Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
    Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
    Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.
    Codran A; Royer C; Jaeck D; Bastien-Valle M; Baumert TF; Kieny MP; Pereira CA; Martin JP
    J Gen Virol; 2006 Sep; 87(Pt 9):2583-2593. PubMed ID: 16894197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
    Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
    Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.
    Panigrahi R; Chandra PK; Ferraris P; Kurt R; Song K; Garry RF; Reiss K; Coe IR; Furihata T; Balart LA; Wu T; Dash S
    J Virol; 2015 Jan; 89(1):626-42. PubMed ID: 25339775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process.
    Lv XQ; Zou LL; Tan JL; Li H; Li JR; Liu NN; Dong B; Song DQ; Peng ZG
    Eur J Pharmacol; 2020 Sep; 883():173323. PubMed ID: 32622669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of silibinin on hepatitis B virus entry.
    Umetsu T; Inoue J; Kogure T; Kakazu E; Ninomiya M; Iwata T; Takai S; Nakamura T; Sano A; Shimosegawa T
    Biochem Biophys Rep; 2018 Jul; 14():20-25. PubMed ID: 29872730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles.
    Meertens L; Bertaux C; Dragic T
    J Virol; 2006 Dec; 80(23):11571-8. PubMed ID: 17005647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.
    Descamps V; Helle F; Louandre C; Martin E; Brochot E; Izquierdo L; Fournier C; Hoffmann TW; Castelain S; Duverlie G; Galmiche A; François C
    Antiviral Res; 2015 Jun; 118():93-102. PubMed ID: 25823619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly bioavailable silibinin nanoparticles inhibit HCV infection.
    Liu CH; Lin CC; Hsu WC; Chung CY; Lin CC; Jassey A; Chang SP; Tai CJ; Tai CJ; Shields J; Richardson CD; Yen MH; Tyrrell DLJ; Lin LT
    Gut; 2017 Oct; 66(10):1853-1861. PubMed ID: 27436270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative endocytosis pathway for productive entry of hepatitis C virus.
    Matsuda M; Suzuki R; Kataoka C; Watashi K; Aizaki H; Kato N; Matsuura Y; Suzuki T; Wakita T
    J Gen Virol; 2014 Dec; 95(Pt 12):2658-2667. PubMed ID: 25096815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
    Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E
    Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.